NLRP3 and atherosclerosis: In a TET-2 mutated CH model, for example, monocyte-macrophages are activated with up-regulation of IL-1β signaling, mediated by the activated NLRP3 inflammasome, accelerating atherosclerosis development and maladaptive cardiac remodeling in mice [12–14].